-
PBLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Panbela Therapeutics (PBLA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 142.00 k | 142.00 k | 142.00 k | 142.00 k | 142.00 k | 142.00 k |
Cash burn (monthly) | (no burn) | 63.75 k | 2.39 mm | 2.46 mm | 706.67 k | 1.30 mm |
Cash used (since last report) | n/a | 324.07 k | 12.15 mm | 12.53 mm | 3.59 mm | 6.60 mm |
Cash remaining | n/a | -182.07 k | -12.01 mm | -12.39 mm | -3.45 mm | -6.45 mm |
Runway (months of cash) | n/a | -2.9 | -5.0 | -5.0 | -4.9 | -5.0 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 590.00 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Lind Global Fund II | 590.00 k | $0.00 |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Oct 24 | Horvath Susan | Stock Option Common Stock | Grant | Acquire A | No | No | 0.389 | 25,480 | 9.91 k | 25,480 |
1 Oct 24 | Simpson Jennifer K. | Stock Option Common Stock | Grant | Acquire A | No | No | 0.389 | 72,800 | 28.32 k | 72,800 |
8 Nov 23 | The Goldman Sachs Group, Inc. | Common Stock | Sell | Dispose S | Yes | No | 0.71 | 72,874 | 51.74 k | 397,954 |